Effects of telmisartan on proteinuria or albuminuria: A meta-analysis of randomized trials

International Journal of Cardiology

Volumn 167, Issue 4, 2013, Pages 1443-1449

  Takagi, Hisato ^a   Yamamoto, Hirotaka ^a   Iwata, Kotaro ^a   Goto, Shin Nosuke ^a   Umemoto, Takuya ^a  

^a SHIZUOKA MEDICAL CENTER   (Japan)

Author keywords

Albuminuria; Meta analysis; Proteinuria; Randomized trial; Telmisartan

Indexed keywords

ALBUMIN; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CANDESARTAN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDROCHLOROTHIAZIDE; LISINOPRIL; LOSARTAN; OLMESARTAN; PERINDOPRIL; PLACEBO; RAMIPRIL; TELMISARTAN; VALSARTAN;

ALBUMINURIA; ARTICLE; COCHRANE LIBRARY; DRUG DOSE COMPARISON; DRUG EFFICACY; EMBASE; HUMAN; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT OUTCOME; URINARY EXCRETION;

ALBUMINURIA; META-ANALYSIS; PROTEINURIA; RANDOMIZED TRIAL; TELMISARTAN;

ALBUMINURIA; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BENZIMIDAZOLES; BENZOATES; HUMANS; PROTEINURIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84881476573     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.04.058     Document Type: Article

References (38)

1. J.F. Mann, R.E. Schmieder, and L. Dyal Effect of telmisartan on renal outcomes: a randomized trial Ann Intern Med 151 1-10 2009 W1 W2
2. J.F. Mann, R.E. Schmieder, and M. McQueen Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial Lancet 372 2008 547 553
3. G. Bakris, E. Burgess, M. Weir, G. Davidai, S. Koval, and AMADEO Study Investigators Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy Kidney Int 74 2008 364 369
4. J. Galle, E. Schwedhelm, S. Pinnetti, R.H. Böger, C. Wanner, and VIVALDI investigators Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy Nephrol Dial Transplant 23 2008 3174 3183
5. Higgins JP, Deeks JJ, Altman DG, editors. Chapter 16: special topics in statistics. In: Higgins JP, Green S, editors. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration; 2011. Available from www.cochrane-handbook.org.
6. D. Follmann, P. Elliott, I. Suh, and J. Cutler Variance imputation for overviews of clinical trials with continuous response J Clin Epidemiol 45 1992 769 773
7. T. Arai, and H. Ohashi Angiotensin receptor blockers and microalbuminuria in hypertensive patients with early (microalbuminuric) stage diabetic nephropathy Mol Med Rep 1 2008 391 393
8. S. Masuda, K. Tamura, and H. Wakui Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy Hypertens Res 32 2009 950 955
9. T. Nakamura, N. Fujiwara, E. Sato, Y. Ueda, T. Sugaya, and H. Koide Renoprotective effects of various angiotensin II receptor blockers in patients with early-stage diabetic nephropathy Kidney Blood Press Res 33 2010 213 220
10. N. Ozaki, Y. Nomura, H. Sobajima, K. Kondo, and Y. Oiso Comparison of the effects of three angiotensin II receptor type 1 blockers on metabolic parameters in hypertensive patients with type 2 diabetes mellitus Eur J Intern Med 21 2010 236 239
11. Y. Yano, S. Hoshide, and J. Ishikawa The differential effects of angiotensin II type 1 receptor blockers on microalbuminuria in relation to low-grade inflammation in metabolic hypertensive patients Am J Hypertens 20 2007 565 572
12. A.H. Barnett, S.C. Bain, and P. Bouter Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy N Engl J Med 351 2004 1952 1961
13. U. Krairittichai, and V. Chaisuvannarat Effects of dual blockade of renin-angiotensin system in type 2 diabetes mellitus patients with diabetic nephropathy J Med Assoc Thai 92 2009 611 617
14. T. Nakamura, K. Kawachi, and Y. Saito Effects of ARB or ACE-inhibitor administration on plasma levels of aldosterone and adiponectin in hypertension Int Heart J 50 2009 501 512
15. T. Nakamura, N. Fujiwara, Y. Kawagoe, T. Sugaya, Y. Ueda, and H. Koide Effects of telmisartan and enalapril on renoprotection in patients with mild to moderate chronic kidney disease Eur J Clin Invest 40 2010 790 796
16. T. Nakamura, E. Sato, and N. Fujiwara Changes in urinary albumin excretion, inflammatory and oxidative stress markers in ADPKD patients with hypertension Am J Med Sci 343 2012 46 51
17. A.M. Sengul, Y. Altuntas, A. Kürklü, and L. Aydin Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension Diabetes Res Clin Pract 71 2006 210 219
18. L. Vogt, G. Navis, and J. Köster The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial J Hypertens 23 2005 2055 2061
19. H. Makino, M. Haneda, and T. Babazono Microalbuminuria reduction with telmisartan in normotensive and hypertensive Japanese patients with type 2 diabetes: a post-hoc analysis of The Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) study Hypertens Res 31 2008 657 664
20. K. Kinouchi, A. Ichihara, M. Sakoda, A. Kurauchi-Mito, K. Murohashi-Bokuda, and H. Itoh Effects of telmisartan on arterial stiffness assessed by the cardio-ankle vascular index in hypertensive patients Kidney Blood Press Res 33 2010 304 312
21. S. Morimoto, Y. Yano, K. Maki, and K. Sawada Renal and vascular protective effects of telmisartan in patients with essential hypertension Hypertens Res 29 2006 567 572
22. T. Nakamura, T. Inoue, and T. Suzuki Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency Hypertens Res 31 2008 841 850
23. R. Kunz, C. Friedrich, M. Wolbers, and J.F. Mann Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease Ann Intern Med 148 2008 30 48
24. R.T. Gansevoort, K. Matsushita, and M. van der Velde Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts Kidney Int 80 2011 93 104
25. C. Cerezo, L.M. Ruilope, and J. Segura Microalbuminuria breakthrough under chronic renin-angiotensin-aldosterone system suppression J Hypertens 30 2012 204 209
26. G. Remuzzi, A. Benigni, and A. Remuzzi Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes J Clin Invest 116 2006 288 296
27. P.A. Sarafidis, P.C. Stafylas, A.I. Kanaki, and A.N. Lasaridis Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis Am J Hypertens 21 2008 922 929
28. M.C. Wang, W.C. Tsai, J.Y. Chen, and J.J. Huang Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease Am J Kidney Dis 45 2005 494 501
29. E. Preston, M.R. Ellis, E. Kulinskaya, A.H. Davies, and E.A. Brown Association between carotid artery intima-media thickness and cardiovascular risk factors in CKD Am J Kidney Dis 46 2005 856 862
30. H. Uchida, Y. Nakamura, and M. Kaihara Practical efficacy of telmisartan for decreasing morning home blood pressure and pulse wave velocity in patients with mild-to-moderate hypertension Hypertens Res 27 2004 545 550
31. S. Masuda, K. Tamura, and H. Wakui Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy Hypertens Res 32 2009 950 955
32. S.J. Hong, S.C. Choi, C.M. Ahn, J.H. Park, J.S. Kim, and D.S. Lim Telmisartan reduces neointima volume and pulse wave velocity 8 months after zotarolimus-eluting stent implantation in hypertensive type 2 diabetic patients Heart 97 2011 1425 1432
33. H. Hasegawa, H. Takano, and H. Narumi Effects of telmisartan and losartan on cardiovascular protection in Japanese hypertensive patients Hypertens Res 34 2011 1179 1184
34. G. Ntaios, C. Savopoulos, and A. Hatzitolios Telmisartan and carotid intima-media thickness regression: a class effect of angiotensin-receptor blockers? Hypertens Res 31 2008 2187 2188 author reply 2188
35. P.A. Sarafidis, P.C. Stafylas, P.I. Georgianos, A.N. Saratzis, and A.N. Lasaridis Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis Am J Kidney Dis 55 2010 835 847
36. S.C. Benson, H.A. Pershadsingh, and C.I. Ho Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity Hypertension 43 2004 993 1002
37. S.B. Nicholas, Y. Kawano, S. Wakino, A.R. Collins, and W.A. Hsueh Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells Hypertension 37 2001 722 727
38. P.A. Sarafidis, and G.L. Bakris Protection of the kidney by thiazolidinediones: an assessment from bench to bedside Kidney Int 70 2006 1223 1233